Epigenetic silencing of multiple interferon pathway genes after cellular immortalization

Oncogene

Volumn 22, Issue 26, 2003, Pages 4118-4127

  Kulaeva, Olga I ^a   Draghici, Sorin ^b   Tang, Lin ^a   Kraniak, Janice M ^a   Land, Susan J ^a   Tainsky, Michael A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Immortalization; Interferon gene silencing; LI Fraumeni syndrome; Senescence

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE INHIBITOR; INTERFERON; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL IMMORTALIZATION; CONTROLLED STUDY; DNA FINGERPRINTING; DNA METHYLATION; DNA MICROARRAY; EARLY DIAGNOSIS; ENZYME INHIBITION; EPIGENETIC SILENCING; FAMILIAL CANCER; FIBROBLAST; GENE EXPRESSION REGULATION; GENE SILENCING; GROWTH INHIBITION; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; METHYLATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; SENESCENCE; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE;

ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; CELL DIVISION; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOWN-REGULATION; FIBROBLASTS; GENE SILENCING; HUMANS; INTERFERONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES; PHENOTYPE; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 0038677615     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206594     Document Type: Article

References (50)

1. Agrawal S, Agarwal ML, Chatterjee-Kishore M, Stark GR and Chisolm GM. (2002). Mol. Cell. Biol., 22, 1981-1992.
2. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K and Herman JG. (2001). Hum. Mol. Genet., 10, 687-692.
3. Bechter OE, Eisterer W, Dlaska M, Kuhr T and Thaler J. (2002). Exp. Hematol., 30, 26-33.
4. Bender CM, Pao MM and Jones PA. (1998). Cancer Res., 58, 95-101.
5. Berube NG, Smith JR and Pereira-Smith OM. (1998). Am. J. Hum. Genet., 62, 1015-1019.
6. Bischoff FZ, Yim SO, Pathak S, Grant G, Siciliano MJ, Giovanella BC, Strong LC and Tainsky MA. (1990). Cancer Res., 50, 7979-7984.
7. Brown R and Strathdee G. (2002). Expert Opin. Invest. Drugs, 11, 747-754.
8. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA and Reddel RR. (1997). Nat. Med., 3, 1271-1274.
9. Bryan TM, Englezou A, Gupta J, Bacchetti S and Reddel RR. (1995). EMBO J., 14, 4240-4248.
10. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, Faruque M, Moses T, Ewing C, Gillanders E, Hu P, Bujnovszky P, Makalowska I, Baffoe-Bonnie A, Faith D, Smith J, Stephan D, Wiley K, Brownstein M, Gildea D, Kelly B, Jenkins R, Hostetter G, Matikainen M, Schleutker J, Klinger K, Connors T, Xiang Y, Wang Z, De Marzo A, Papadopoulos N, Kallioniemi OP, Burk R, Meyers D, Gronberg H, Meltzer P, Silverman R, Bailey-Wilson J, Walsh P, Isaacs W and Trent J. (2002). Nat. Genet., 30, 181-184.
11. Choubey D and Lengyel P. (1995). J. Biol. Chem., 270, 6134-6140.
12. Dessain SK, Yu H, Reddel RR, Beijersbergen RL and Weinberg RA. (2000). Cancer Res., 60, 537-541.
13. DeYoung KL, Ray ME, Su YA, Anzick SL, Johnstone RW, Trapani JA, Meltzer PS and Trent JM. (1997). Oncogene, 15, 453-457.
14. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith, Peacocke M and Campisi J. (1995). Proc. Natl. Acad. Sci. USA, 92, 9363-9367.
15. Draghici S. (2002). Drug Discov. Today, 7, S55-S63.
16. D'Souza S, Xin H, Walter S and Choubey D. (2001). J. Biol. Chem., 276, 298-305.
17. Duncan EL, Wadhwa R and Kaul SC. (2000). Biogerontology, 1, 103-121.
18. Dunham MA, Neumann AA, Fasching CL and Reddel RR. (2000). Nat. Genet., 26, 447-450.
19. Fairweather NF, Lyness VA and Maskell DJ. (1987). Infect. Immun., 55, 2541-2545.
20. Gardiner-Garden M and Frommer M. (1987). J. Mol. Biol., 196, 261-282.
21. Gollahon LS, Kraus E, Wu TA, Yim SO, Strong LC, Shay JW and Tainsky MA. (1998). Oncogene, 17, 709-717.
22. Graham FL, Smiley J, Russell WC and Nairn R. (1977). J. Gen. Virol., 36, 59-74.
23. Gutman A and Wasylyk B. (1991). Trends Genet., 7, 49-54.
24. Harada H, Kitagawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M and Taniguchi T. (1993). Science, 259, 971-974.
25. Harada M, Li YF, El-Gamil M, Ohnmacht GA, Rosenberg SA and Robbins PF. (2001). J. Immunother., 24, 323-333.
26. Hayflick L. (1976). N. Engl. J. Med., 295, 1302-1308.
27. Herman JG and Baylin SB. (2000). Curr. Top. Microbiol. Immunol., 249, 35-54.
28. Huschtscha LI and Holliday R. (1983). J. Cell. Sci., 63, 77-99.
29. Jagus R, Joshi B and Barber GN. (1999). Int. J. Biochem. Cell. Biol., 31, 123-138.
30. Jay P, Rougeulle C, Massacrier A, Moncla A, Mattei MG, Malzac P, Roeckel N, Taviaux S, Lefranc JL, Cau P, Berta P, Lalande M and Muscatelli F. (1997). Nat. Genet., 17, 357-361.
31. Karpf AR, Peterson PW, Rawlins JT, Dalley BK, Yang Q, Albertsen H and Jones DA. (1999). Proc. Natl. Acad. Sci. USA, 96, 14007-14012.
32. Kerr MK, Martin M and Churchill GA. (2000). J. Comput. Biol., 7, 819-837.
33. Liang G, Gonzales FA, Jones PA, Orntoft TF and Thykjaer T. (2002). Cancer Res., 62, 961-966.
34. Malkin D. (1994). Biochim. Biophys. Acta, 1198, 197-213.
35. Malkin D, Li FP, Strong LC, Fraumeni Jr JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA and Friend SH. (1990). Science, 250, 1233-1238.
36. Mori Y, Yin J, Rashid A, Leggett BA, Young J, Simms L, Kuehl PM, Langenberg P, Meltzer SJ and Stine OC. (2001). Cancer Res., 61, 6046-6049.
37. Nakada Y, Taniura H, Uetsuki T, Inazawa J and Yoshikawa K. (1998), Gene, 213, 65-72.
38. Newell-Price J, Clark AJ and King P. (2000). Trends Endocrinol. Metab., 11, 142-148.
39. Noda A, Ning Y, Venable SF, Pereira-Smith OM and Smith JR. (1994). Exp. Cell. Res., 211, 90-98.
40. Pereira-Smith OM and Smith JR. (1983). Science, 221, 964-966.
41. Pereira-Smith OM and Smith JR. (1988). Proc. Natl. Acad. Sci. USA, 85, 6042-6046.
42. Rogan EM, Bryan TM, Hukku B, Maclean K, Chang AC, Moy EL, Englezou A, Warneford SG, Dalla-Pozza L and Reddel RR. (1995). Mol. Cell. Biol., 15, 4745-4753.
43. Schwarze SR, DePrimo SE, Grabert LM, Fu VX, Brooks JD and Jarrard DF. (2002). J. Biol. Chem., 277, 14877-14883.
44. Shay JW, Tomlinson G, Piatyszek MA and Gollahon LS. (1995). Mol. Cell. Biol., 15, 425-432.
45. Shelton DN, Chang E, Whittier PS, Choi D and Funk WD, (1999). Curr. Biol., 9, 939-945.
46. Vogt M, Haggblom C, Yeargin J, Christiansen-Weber T and Haas M. (1998). Cell. Growth Differ., 9, 139-146.
47. Wen Y, Yan DH, Wang B, Spohn B, Ding Y, Shao R, Zou Y, Xie K and Hung MC. (2001). Cancer Res., 61, 7142-7147.
48. Willman CL, Sever CE, Pallavicini MG, Harada H, Tanaka N, Slovak ML, Yamamoto H, Harada K, Meeker TC, List AF and Taniguchi T. (1993). Science, 259, 968-971.
49. Xin H, D'Souza S, Fang L, Lengyel P and Choubey D. (2001). Oncogene, 20, 6828-6839.
50. Young JI and Smith JR. (2001). J. Biol. Chem., 276, 19610-19616.